Abx Pentra Amylase Cp and 5 more
Catalytic Methods, Amylase. 510(k) K062180, from Horiba Abx (Montpellier, FR). Product code JFJ, class 2.
As of Nov 18, 2026, K062180 is an FDA 510(k) held by Horiba Abx, substantially equivalent on Oct 2, 2006 after 63 days, with no recalls tied to it in FDA's recall database.
- Review time: 63 days
- Recalls: 0
- Cited as a predicate by: 1 device
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFAmylase reagent, with associated calibrators and controls, are intended for use on ABX PENTRA 400 Clinical Chemistry Analyzer to measure amylase analyte. ABX PENTRA Amylase CP reagent with associated calibrators and controls are for quantitative in vitro diagnostic determination of the activity of the enzyme amylase in human serum and plasma based on an enzymatic photometric assay.
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Cobas Reagent for A-AmylaseK801295 · Roche Analytical Instruments, Inc. · Jul 8, 1980
- Abx Pentra 400 Clinical Chemistry Analyzer (Option: I.S.E. Module)K052007 · Horiba Abx · Dec 16, 2005
Cited as a predicate
1 later 510(k) summary names this device as a predicate- Abx Pentra Calcium As CP, Abx Pentra Urine Control L/H, Abx Pentra Multical, Abx Pentra N Control, and Abx Pentra P ContK123171 · Horiba Abx SAS · Jul 3, 2013
Other JFJ clearances
The newest 510(k)s for the same product code; see every JFJ device- Amylase2K210633 · Abbott Ireland Diagnostics Division · May 26, 2022
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 31, 2006
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1070
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files